MTEM Stock Summary and Trading Ideas (Molecular Templates | NASDAQ:MTEM)

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Molecular Templates trades on the NASDAQ stock market under the symbol MTEM.

As of May 6, 2024, MTEM stock price declined to $1.64 with 54,730 million shares trading.

MTEM has a beta of 0.20, meaning it tends to be less sensitive to market movements. MTEM has a correlation of 0.00 to the broad based SPY ETF.

MTEM has a market cap of $10.80 million. This is considered a Sub-Micro Cap stock.

Last quarter Molecular Templates reported $7 million in Revenue and -$.73 earnings per share. This fell short of revenue expectation by $-754,000 and exceeded earnings estimates by $.24.

In the last 3 years, MTEM stock traded as high as $143.25 and as low as $1.40.

The top ETF exchange traded funds that MTEM belongs to (by Net Assets): VTI, VXF.

MTEM has underperformed the market in the last year with a return of -71.7%, while the SPY ETF gained +28.3%. In the last 3 month period, MTEM fell short of the market, returning -55.4%, while SPY returned +4.8%. However, in the most recent 2 weeks MTEM has outperformed the stock market by returning +11.6%, while SPY returned +4.3%.

MTEM support price is $1.56 and resistance is $1.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MTEM stock will trade within this expected range on the day.